Proliferative activity in breast carcinoma evaluated bv BrdU and PCNA: Correlation with expression of p53, c-erbB-2, estrogen receptor and P-Glycoprotein
- 30 November 1995
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 191 (11) , 1122-1132
- https://doi.org/10.1016/s0344-0338(11)80657-6
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Analysis of cerbB2 expression using a panel of 6 commercially available antibodiesPathology, 1994
- Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis?Human Pathology, 1993
- Overexpression of p53 as a Possible Prognostic Factor in Human Thyroid CarcinomaThe American Journal of Surgical Pathology, 1993
- Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situHuman Pathology, 1990
- Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood.Journal of Clinical Oncology, 1990
- Factors affecting relapse in node-negative breast cancer. A multivariate analysis including the labeling indexEuropean Journal of Cancer and Clinical Oncology, 1989
- Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variablesThe Journal of Pathology, 1987
- Cyclin/PCNA is the auxiliary protein of DNA polymerase-δNature, 1987
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986
- Histological Grading and Prognosis in Breast CancerBritish Journal of Cancer, 1957